Royal Bank of Canada’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $233K | Buy |
+31,232
| New | +$233K | ﹤0.01% | 4713 |
|
2024
Q2 | – | Sell |
-270
| Closed | -$2K | – | 6895 |
|
2024
Q1 | $2K | Sell |
270
-2,077
| -88% | -$15.4K | ﹤0.01% | 6235 |
|
2023
Q4 | $19K | Buy |
2,347
+1,259
| +116% | +$10.2K | ﹤0.01% | 5795 |
|
2023
Q3 | $14K | Sell |
1,088
-1,604
| -60% | -$20.6K | ﹤0.01% | 5818 |
|
2023
Q2 | $43K | Buy |
+2,692
| New | +$43K | ﹤0.01% | 5391 |
|
2022
Q4 | – | Sell |
-76
| Closed | -$1K | – | 7016 |
|
2022
Q3 | $1K | Buy |
+76
| New | +$1K | ﹤0.01% | 6737 |
|